- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/04 - Immunostimulants
Patent holdings for IPC class A61P 37/04
Total number of patents in this class: 5772
10-year publication summary
|
263
|
233
|
299
|
358
|
370
|
496
|
543
|
493
|
589
|
251
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1636 |
68 |
| The Trustees of the University of Pennsylvania | 4308 |
57 |
| The Regents of the University of California | 19812 |
52 |
| Osaka University | 3362 |
42 |
| National Research Council of Canada | 1548 |
40 |
| The Governors of the University of Alberta | 862 |
37 |
| University of Saskatchewan | 477 |
36 |
| Bristol-myers Squibb Company | 4892 |
35 |
| The University of British Columbia | 1492 |
34 |
| Toray Industries, Inc. | 6891 |
30 |
| Nestec S.A. | 2679 |
29 |
| Memorial Sloan-Kettering Cancer Center | 1910 |
28 |
| Universite de Montreal | 343 |
27 |
| The University of Tokyo | 4148 |
26 |
| Inovio Pharmaceuticals, Inc. | 317 |
25 |
| Merck Sharp & Dohme LLC | 3741 |
25 |
| Pfizer Inc. | 3367 |
24 |
| Immatics Biotechnologies GmbH | 1152 |
24 |
| Kyoto University | 2793 |
24 |
| Riken | 1688 |
24 |
| Other owners | 5085 |